-
Mashup Score: 0
An analysis of chronic kidney disease (CKD) trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Nephrology Videos | Docwire News - 1 day(s) ago
Read the latest research and news curated for nephrology videos.
Source: www.docwirenews.comCategories: General Medicine News, NephrologyTweet-
🎥 🎬 Lights, camera, action! Check out our exclusive video interviews with #nephrology researchers and experts here ➡️ https://t.co/ERSJZy9MpL
-
-
Mashup Score: 1
Several genetically predicted environmental factors increase the risk of IgA nephropathy (IgAN) and membranous nephropathy (MN), a study found.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Certain genetically predicted #environmentalfactors increase the risk of #IgAN and #membranousnephropathy. #nephrology #nephtwitter #iganephropathy https://t.co/x1Fg7YzqJQ https://t.co/wDIvbAutFq
-
-
Mashup Score: 0Minimizing Glucocorticoid Use in Patients With ANCA-Associated Vasculitis | Docwire News - 3 day(s) ago
A study found that combination cyclophosphamide and rituximab therapy for severe ANCA-associated vasculitis to minimize glucocorticoid use may reduce morbidity.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Cyclophosphamide-rituximab therapy and minimal use of glucocorticoids in ANCA-associated vasculitis may reduce morbidity. #AAV #ANCAvasculitis #nephrology #rituximab #cyclophosphamide #glucocorticoids https://t.co/tBTm8YuCHR https://t.co/kpiKth1sw7
-
-
Mashup Score: 0
Proteinuria trajectory is a major predictor of disease progression in children and adults with IgA nephropathy (IgAN), a study found.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Identifying patients with #IgAN who are at risk for disease progression is critical—and #proteinuria trajectory is a major predictor. #nephrology #iganephropathy #nephtwitter https://t.co/ksZWoIWMpx https://t.co/RgX1hwKgvM
-
-
Mashup Score: 0
Rajiv Agarwal, MBBS, discussed a study showing that a finerenone and empagliflozin combination has superior efficacy at reducing UACR in chronic kidney disease and type 2 diabetes.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
✔️ Check out our interview with @AgarwalRajivMD, who presented at #ERA25 on the efficacy of pairing #finerenone and #empagliflozin to lower UACR. #nephtwitter #nephrology #kidneydisease #ckd #diabetes https://t.co/NXWSVTd9Xk https://t.co/OBPe1Lcov2
-
-
Mashup Score: 0
Dr. Richard Furie spoke with Nephrology Times about new data from the BLISS-LN study supporting the efficacy and safety of belimumab for active proliferative lupus nephritis (LN).
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
WATCH: Dr. Richard Furie spoke with us about a post hoc subgroup analysis of BLISS-LN in which belimumab demonstrated enhanced renal responses in lupus nephritis. #nephrology #nephtwitter #rheumatology #lupus #lupusnephritis #belimumab @NorthwellHealth https://t.co/nh95xIHSGu https://t.co/D2EpxhJozs
-
-
Mashup Score: 0Study Identifies microRNA-483-5p as Potential Biomarker for IgAN Progression | Docwire News - 5 day(s) ago
Research identified microRNA-483-5p as a possible biomarker for IgA nephropathy (IgAN) to help with risk stratification.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
The role of extracellular microRNAs in intercellular communication is gaining recognition for its role on inflammatory and scarring pathways in the kidneys. #microRNA #IgAN #IgAnephropathy #biomarkers #nephtwitter #nephrology https://t.co/Y4NyVAlBwN https://t.co/x561kJkx53
-
-
Mashup Score: 1
The race of patients with autosomal polycystic kidney disease (ADPKD) influences their waitlist experience, allograft quality, and post-transplant outcomes, a study found.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
How does race affect #transplantation outcomes for patients with #ADPKD? #kidneytransplantation #nephrology #nephtwitter #disparities https://t.co/JhUskK6IeA https://t.co/iuCXndJtsC
-
-
Mashup Score: 2
Phase 3 VISIONARY trial data presented at the ERA Congress 2025 showed sibeprenlimab helps achieve significant proteinuria reduction in patients with IgA nephropathy (IgAN).
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Interim results of VISIONARY presented in a late-breaking abstract at #ERA25 showed that #sibeprenlimab helps achieve significant #proteinuria reduction in patients with #IgAN. #IgAnephropathy #nephrology #nephtwitter @VladoPerkovic @ERAkidney https://t.co/1IKp7ciTcj https://t.co/rhAby9opYN
-
Study findings support using the 3-year #eGFR slope as the primary slope-based outcome in randomized #CKD trials. #kidneydisease #nephtwitter #nephrology https://t.co/Q3Y4Z0yANS https://t.co/uVMTeOHmEc